Facebook
X
LinkedIn
ForwardEM2604H"Rewriting the Chapter on Cystic Fibrosis" (IM GR-040326)
Purpose and Overview
The goal is to describe the arc of discovery for the genetic disease cystic fibrosis. The story begins with description of the disease in the clinic, extends to the scientific research lab for mechanistic understanding, progresses to industry with development of new medicines, and then returns to people with cystic fibrosis and dramatically improves their lives.
Target Audience
UT Southwestern faculty, fellows, residents and medical students, community physicians, nurse clinicians, physician assistants and nurses.
Learning Objectives
At the conclusion of this activity, the participant should be able to:
- Understand the pathway that leads to improved treatments.
- Realize that new medicines targeting specific mutations improve the lives of some people with cystic fibrosis.
- Know what CFTR does and how mutations disrupt its function.
Michael J. Welsh, M.D.
Professor of Internal Medicine, Molecular Phsyiology & Biophysics
Division of Pulmonary, Critical Care & Occupational Medicine
Roy J. and Lucille A. Carver College of Medicine
University of Iowa
Available Credit
- 1.00 AMA
Price
Required Hardware/software
Activities should be run with recent versions of common browsers, including Internet Explorer, Firefox and Google Chrome